| Year |
Citation |
Score |
| 2023 |
Shankara Narayanan JS, Hayashi T, Erdem S, McArdle S, Tiriac H, Ray P, Pu M, Mikulski Z, Miller A, Messer K, Carson D, Schoenberger S, White RR. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model. Journal For Immunotherapy of Cancer. 11. PMID 36634919 DOI: 10.1136/jitc-2022-006133 |
0.297 |
|
| 2022 |
Pereira de Jesus BA, Gomes AA, Clark AE, Rodrigues TA, Ledgerwood-Lee M, Van Zant W, Brickner H, Wang M, Blum DL, Cassera MB, Carlin AF, Aronoff-Spencer ES, da Silva GF, Magalhães MLB, Ray P. In Vitro Diagnostic Assay to Detect SARS-CoV-2-Neutralizing Antibody in Patient Sera Using Engineered ACE-2 Mini-Protein. Viruses. 14. PMID 36560827 DOI: 10.3390/v14122823 |
0.292 |
|
| 2022 |
Vijayakumar S, Nasr SH, Davis JE, Wang E, Zuidema JM, Lu YS, Lo YH, Sicklick JK, Sailor MJ, Ray P. Anti-KIT DNA aptamer-conjugated porous silicon nanoparticles for the targeted detection of gastrointestinal stromal tumors. Nanoscale. PMID 36416809 DOI: 10.1039/d2nr03905b |
0.304 |
|
| 2022 |
Clark V, Waters K, Orsburn B, Bumpus NN, Kundu N, Sczepanski JT, Ray P, Arroyo-Currás N. Human Cyclophilin B Nuclease Activity Revealed via Nucleic Acid-Based Electrochemical Sensors. Angewandte Chemie (International Ed. in English). PMID 35999181 DOI: 10.1002/anie.202211292 |
0.28 |
|
| 2022 |
Fernandes LA, Gomes AA, Guimarães BG, de Lourdes Borba Magalhães M, Ray P, da Silva GF. Engineering defensin α-helix to produce high-affinity SARS-CoV-2 spike protein binding ligands. Protein Science : a Publication of the Protein Society. 31: e4355. PMID 35634778 DOI: 10.1002/pro.4355 |
0.295 |
|
| 2022 |
Shankara Narayanan JSN, Frizzi K, Erdem S, Ray P, Jaroch D, Cox B, Katz S, Vicente D, White R. Oxaliplatin-induced peripheral neuropathy can be minimized by pressurized regional intravascular delivery in an orthotopic murine pancreatic cancer model. Discover. Oncology. 13: 21. PMID 35384564 DOI: 10.1007/s12672-022-00483-4 |
0.271 |
|
| 2021 |
Singh NK, Ray P, Carlin AF, Morgan SC, Magallanes C, Laurent LC, Aronoff-Spencer ES, Hall DA. Dataset on optimization and development of a point-of-care glucometer-based SARS-CoV-2 detection assay using aptamers. Data in Brief. 107278. PMID 34401413 DOI: 10.1016/j.dib.2021.107278 |
0.28 |
|
| 2021 |
Chung S, Sicklick JK, Ray P, Hall DA. Development of a Soluble KIT Electrochemical Aptasensor for Cancer Theranostics. Acs Sensors. PMID 34008963 DOI: 10.1021/acssensors.1c00535 |
0.305 |
|
| 2021 |
Singh NK, Ray P, Carlin AF, Magallanes C, Morgan SC, Laurent LC, Aronoff-Spencer ES, Hall DA. Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer. Biosensors & Bioelectronics. 180: 113111. PMID 33743492 DOI: 10.1016/j.bios.2021.113111 |
0.247 |
|
| 2020 |
Huang CC, Ray P, Chan M, Zhou X, Hall DA. An aptamer-based magnetic flow cytometer using matched filtering. Biosensors & Bioelectronics. 169: 112362. PMID 32911314 DOI: 10.1016/J.Bios.2020.112362 |
0.364 |
|
| 2020 |
Shankara Narayanan JS, Vicente DA, Ray P, Chai LF, Erdem S, Carr MJ, Capacio BA, Cox BF, Jaroch DB, Katz SC, White RR. Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model. Surgery. PMID 32620306 DOI: 10.1016/J.Surg.2020.04.059 |
0.381 |
|
| 2020 |
Banerjee S, Yoon H, Yebra M, Tang CM, Gilardi M, Shankara Narayanan JS, White RR, Sicklick JK, Ray P. Anti-KIT DNA Aptamer for Targeted Labeling of Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. PMID 32127469 DOI: 10.1158/1535-7163.Mct-19-0959 |
0.419 |
|
| 2020 |
Vicente D, Narayanan JS, Ray P, Chai LF, Erdem S, Carr M, Capacio B, Cox B, Jaroch D, Katz SC, White RR. Comparison of gemcitabine delivery and tumor response in a pressurized pancreatic retrograde venous infusion versus systemic infusion in an orthotopic murine model. Journal of Clinical Oncology. 38: 737-737. DOI: 10.1200/Jco.2020.38.4_Suppl.737 |
0.356 |
|
| 2020 |
Narayanan JSNS, Vicente D, Ray P, Whisenant T, White R. Abstract 2221: Combining irreversible electroporation with TLR7 and CD40 agonists confers systemic anti-tumor immunity in a murine pancreatic cancer model Immunology. DOI: 10.1158/1538-7445.Am2020-2221 |
0.375 |
|
| 2019 |
Shankara Narayanan JS, Ray P, Hayashi T, Whisenant TC, Vicente D, Carson DA, Miller AM, Schoenberger SP, White RR. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Anti-Tumor Immunity in a Murine Pancreatic Cancer Model. Cancer Immunology Research. PMID 31409607 DOI: 10.1158/2326-6066.Cir-19-0101 |
0.386 |
|
| 2018 |
Shankara Narayanan JS, Ray P, Naqvi I, White R. A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation. Journal of Visualized Experiments : Jove. PMID 29939178 DOI: 10.3791/57265 |
0.403 |
|
| 2017 |
Ray P, White RR. Cell-SELEX Identifies a "Sticky" RNA Aptamer Sequence. Journal of Nucleic Acids. 2017: 4943072. PMID 28194280 DOI: 10.1155/2017/4943072 |
0.438 |
|
| 2016 |
Mi J, Ray P, Liu J, Kuan CT, Xu J, Hsu D, Sullenger BA, White RR, Clary BM. In Vivo Selection Against Human Colorectal Cancer Xenografts Identifies an Aptamer That Targets RNA Helicase Protein DHX9. Molecular Therapy. Nucleic Acids. 5: e315. PMID 27115840 DOI: 10.1038/Mtna.2016.27 |
0.611 |
|
| 2016 |
Ray P. Retrotranslocation: Endoplasmic Reticulum's Junk Disposal Mechanism Einstein Journal of Biology and Medicine. 21: 9-13. DOI: 10.23861/Ejbm200421444 |
0.369 |
|
| 2014 |
Naqvi IA, Ray P, Choi SS, Diehl A, White RR. Utilizing RNA aptamers for Biomarker Discovery in a Novel Cell Culture System for Hepatocellular Carcinoma Journal of Surgical Research. 186: 680. DOI: 10.1016/J.Jss.2013.11.904 |
0.358 |
|
| 2013 |
Ray P, Sullenger BA, White RR. Further characterization of the target of a potential aptamer biomarker for pancreatic cancer: cyclophilin B and its posttranslational modifications. Nucleic Acid Therapeutics. 23: 435-42. PMID 24152208 DOI: 10.1089/Nat.2013.0439 |
0.606 |
|
| 2013 |
Ray P, Viles KD, Soule EE, Woodruff RS. Application of aptamers for targeted therapeutics. Archivum Immunologiae Et Therapiae Experimentalis. 61: 255-71. PMID 23563807 DOI: 10.1007/S00005-013-0227-0 |
0.699 |
|
| 2012 |
Ray P, Cheek MA, Sharaf ML, Li N, Ellington AD, Sullenger BA, Shaw BR, White RR. Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells. Nucleic Acid Therapeutics. 22: 295-305. PMID 23030589 DOI: 10.1089/Nat.2012.0353 |
0.612 |
|
| 2012 |
Ray P, Rialon-Guevara KL, Veras E, Sullenger BA, White RR. Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker. The Journal of Clinical Investigation. 122: 1734-41. PMID 22484812 DOI: 10.1172/Jci62385 |
0.602 |
|
| 2011 |
Ray P, Sullenger BA, White RR. Abstract 2817: An RNA aptamer is a potential biomarker for pancreatic cancer Cancer Research. 71: 2817-2817. DOI: 10.1158/1538-7445.Am2011-2817 |
0.619 |
|
| 2010 |
Ray P, White RR. Aptamers for Targeted Drug Delivery. Pharmaceuticals (Basel, Switzerland). 3: 1761-1778. PMID 27713328 DOI: 10.3390/Ph3061761 |
0.45 |
|
| 2008 |
Ray P, Basu U, Ray A, Majumdar R, Deng H, Maitra U. The Saccharomyces cerevisiae 60 S ribosome biogenesis factor Tif6p is regulated by Hrr25p-mediated phosphorylation. The Journal of Biological Chemistry. 283: 9681-91. PMID 18256024 DOI: 10.1074/Jbc.M710294200 |
0.692 |
|
| 2005 |
Chaudhuri SP, Sundaram G, Bhattacharya A, Ray P, Ray A, Chatterjee IB, Chattopadhyay D. Activation of S phase checkpoint by cigarette smoke extract in Schizosaccharomyces pombe. Yeast (Chichester, England). 22: 1223-38. PMID 16278931 DOI: 10.1002/Yea.1309 |
0.658 |
|
| Show low-probability matches. |
